$CYDY..MONSTA!! - CytoDyn is perhaps the greatest hope in the fight against the pandemic. With the drug Leronlimab, the company has developed a remedy that can cure sick people. The drug is currently undergoing another clinical trial to confirm its effectiveness. Tomorrow Monday, CytoDyn will publish further findings. So it is quite possible that the share will go through the roof tomorrow.
Editor's note: Is CytoDyn really the biotech stock with the greatest potential? We have examined the sector for you. You can access the brand new special report here.
This gives CytoDyn the very best chance of making a breakthrough in the fight against Corona. If the positive trends in the studies are confirmed, leronlimab should be used all over the world. A huge sales perspective! Especially since CytoDyn recently announced a price of $ 1,200 per injection.
In any case, the CytoDyn share price has known only one direction for weeks. Since March 26, prices have been rising almost continuously. At the end of March there was an explosion from 0.86 to 3.34 euros. The share corrected somewhat in April, but this week CytoDyn is heading for the 3 euro mark again.
Free download: We examined the companies involved in the fight against Corona and filtered out the stocks with the greatest potential. You can find the results here.
News 
Market Data 
Discover 
